Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma

American Journal of Dermatopathology

Volumn 26, Issue 6, 2004, Pages 447-451

  Plumb, Stephen J ^a,c   Argenyi, Zsolt B ^a   Stone, Mary S ^b   De Young, Barry R ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c NONE   (United States)

Author keywords

Adnexal neoplasms; Cytokeratin 5 6; Immunohistochemistry; Metastatic adenocarcinoma

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 6; FORMALDEHYDE; PARAFFIN;

ADENOCARCINOMA; ADNEXA DISEASE; ARTICLE; BASAL CELL CARCINOMA; BREAST METASTASIS; CELL PROLIFERATION; COLON ADENOCARCINOMA; CONTROLLED STUDY; CUTANEOUS ADNEXAL NEOPLASM; CYLINDROMA; EPITHELIUM; ESOPHAGUS METASTASIS; HIDRADENOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; METASTASIS; NEOPLASM; OVARY ADENOCARCINOMA; PILOMATRIXOMA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROTEIN EXPRESSION; SEBACEOUS CARCINOMA; SEBACEOUS CYST; SEBACEOUS GLAND TUMOR; SEBACEOUS NEVUS; SYRINGOMA; TRICHILEMMOMA; TRICHOEPITHELIOMA;

ADENOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; MALE; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 11444268345     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000372-200412000-00001     Document Type: Article

References (20)

1. Dabbs DJ. Diagnostic Immunohistochemistry, Philadelphia: Churchill Livingstone; 2002.
2. Lin L, Skacel M, Sigel JE, et al. Epithelioid sarcoma: an immunohistochemical analysis evaluating the utility of cytokeratin 5/6 in distinguishing superficial epithelioid sarcoma from spindled squamous cell carcinoma. J Cutan Pathol. 2003;30:114-117.
3. Chu PG, Weiss LM. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod Pathol. 2002;15:6-10.
4. Kaufmann O, Fietze E, Mengs J, et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol. 2001;116:823-830.
5. Sigel JE, Skacel M, Bergfeld WR et al. The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol. 2001;28:520-524.
6. Demirkesen C, Hoede N, Moll R. Epithelial markers and differentiation in adnexal neoplasms of the skin. J Cutan Pathol. 1995;22:518-535.
7. Moll I, Moll R. Comparative cytokeratin analysis of sweat gland ducts and eccrine poromas. Arch Dermatol Res. 1991;283:300-309.
8. Clover J, Oates J, Edwards C. Anti-cytokeratin 5/6: a positive marker for epithelioid mesothelioma. Histopathology. 1997;31:141-143.
9. Ordonez NG. Value of Cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma. Am J Surg Pathol. 1998;22:1215-1221.
10. Qureshi HS, Ormsby AH, Lee MW, et al. The diagnostic utility of p63, CK5/6, CK 7, and CK 20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2004;31:145-152.
11. Jensen K, Kohler S, Rouse RV Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5/6, 7, 17, and 20. Appl Immunohistochem Mol Morphol. 2000;8:310-315.
12. Reis-Filho JS, Simpson PT, Martins A, et al. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 2003;443:122-132. Epub 2003 Jul 16.
13. Ohnishi T, Takizawa H, Watanabe S. Immunohistochemical analysis of cytokeratin and human milk fat globulin expression in mucinous carcinoma of the skin. J Cutan Pathol. 2002;29:38-43.
14. Wallace ML, Longacre TA, Smoller BR. Estrogen and progesterone receptors and anti-gross cystic disease fluid protein 15 (BRST-2) fail to distinguish metastatic breast carcinoma from eccrine neoplasms. Mod Pathol. 1995;8:897-901.
15. Swanson PE, Cherwitz DL, Neumann MP, et al. Eccrine sweat gland carcinoma: an histologic and immunohistochemical study of 32 cases. J Cutan Pathol. 1987;14:65-86.
16. Swanson PE, Mazoujian G, Mills SE, et al. Immunoreactivity for estrogen receptor protein in sweat gland tumors. Am J Surg Pathol. 1991;15:835-841.
17. Eckert F, Schmid U, Hardmeier T, et al. Cytokeratin expression in mucinous sweat gland carcinomas: an immunohistochemical analysis of four cases. Histopathology. 1992;21:161-165.
18. Kanitakis J, al-Rifai I, Faure M, et al. Thomsen-Friedenreich and its precursor (Tn) antigen expression in normal skin and in benign cutaneous tumours: a marker for sebaceous differentiation. Acta Derm Venereol. 1998;78:173-176.
19. Ormsby AH, Snow JL, Su WP, et al. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol 1995;32:711-716.
20. Wick MR, Goellner JR, Wolfe JT III, et al. Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer. 1985;56:1147-1162.